Citadel Advisors »

Leap Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 721k 4.15
2023-09-30 $898k 651k 1.38
2023-06-30 $306k 98k 3.13

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Leap Therapeutics

Baker Bros. Advisors
Citadel Advisors
Samsara BioCapital
683 Capital Management
Vanguard Group
Key Client Fiduciary Advisors
T. Rowe Price Associates
Alyeska Investment Group
Perceptive Advisors
Susquehanna International
Hrt Financial
Advisor Group Holdings
Baystate Wealth Management
Simplex Trading
CNB Bank

View all funds holding Leap Therapeutics